References

  1. Tsujimoto, M., Kakei, Y., Yamano, N., Fujita, T., Ueda, T., Ono, R., Murakami, S., Moriwaki, S., & Nishigori, C. (2023). Clinical trial on the efficacy and safety of NPC-15 for patients with xeroderma pigmentosum exaggerated sunburn reaction type: XP-1 study protocol for a multicentre, double-blinded, placebo-controlled, two-group crossover study followed by a long-term open study in Japan. BMJ Open, 13(3), e068112. https://doi.org/10.1136/bmjopen-2022-068112
  2. Searle, T., Walburn, J., & Norton, S. (2021). A randomised controlled trial to investigate the effectiveness of sustained photoprotective behaviour in xeroderma pigmentosum after intervention. BJPsych Open, 7(S1), S287. https://doi.org/10.1192/bjo.2021.764
  3. Karass, M., Naguib, M. M., Elawabdeh, N., Cundiff, C. A., Thomason, J., Steelman, C. K., Cone, R., Schwenkter, A., Jordan, C., & Shehata, B. M. (2014). Xeroderma Pigmentosa: Three New Cases with an In Depth Review of the Genetic and Clinical Characteristics of the Disease. Fetal and Pediatric Pathology, 34(2), 120–127. https://doi.org/10.3109/15513815.2014.982336
  4. Priya, P. G. S. R., & Janaki, M. G. (2017). Carcinoma esophagus with xeroderma pigmentosa. Journal of Cancer Research and Therapeutics, 14(2), 451–453. https://doi.org/10.4103/jcrt.jcrt_1264_16
  5. Matsumoto, M., Kaneshiro, K., & Takatsuki, K. (2021). Lung adenocarcinoma concomitant with xeroderma pigmentosum: a case report. Journal of Medical Case Reports, 15(1). https://doi.org/10.1186/s13256-021-02754-0
  6. Sharma, S., Hashmi, M. F., & Chakraborty, R. K. (2020). StatPearls [internet].
  7. Lucero, R., & Horowitz, D. (2023, July 4). Xeroderma Pigmentosum. StatPearls - NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK551563/
  8. Mamada, A., Miura, K., Tsunoda, K., Hirose, I., Furuya, M., & Kondo, S. (1992). Xeroderma pigmentosum Variant Associated with Multiple Skin Cancers and a Lung Cancer. Dermatology, 184(3), 177–181. https://doi.org/10.1159/000247536
  9. Alzubaidi, A., Kaur, J., Mahmud, M., Brown, D. J., He, J., Ball, G., Baldwin, D. R., O’Dowd, E., & Hubbard, R. B. (2021). Selecting Lung Cancer Patients from UK Primary Care Data: A Longitudinal Study of Feature Trends. In Communications in computer and information science (pp. 43–59). https://doi.org/10.1007/978-3-030-82269-9_4
  10. Hoffmann, M., Reitz, D., Taugner, J., Roengvoraphoj, O., Käsmann, L., Eze, C., Karin, M., Belka, C., & Manapov, F. (2020). Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy. Anticancer Research, 40(4), 2319–2322. https://doi.org/10.21873/anticanres.14198
  11. Côté, E., & Micieli, J. A. (2020). Vertical One-and-a-Half Syndrome Due to Metastatic Spindle Cell Carcinoma of the Lung. Canadian Journal of Neurological Sciences / Journal Canadien Des Sciences Neurologiques, 47(5), 685–686. https://doi.org/10.1017/cjn.2020.100
  12. Dillard, T. A., Patel, R. R., & Schroeder, C. (2015). Uneven Distribution of Cancer Histology in the National Lung Screening Trial. The American Journal of the Medical Sciences, 350(3), 219–221. https://doi.org/10.1097/maj.0000000000000516
  13. DeWitt, J., Cho, C., Lin, J., Al-Haddad, M., Canto, M., Salamone, A., Hruban, R., Messallam, A., & Khashab, M. (2015). Comparison of EUS-guided tissue acquisition using two different 19-gauge core biopsy needles: a multicenter, prospective, randomized, and blinded study. Endoscopy International Open, 03(05), E471–E478. https://doi.org/10.1055/s-0034-1392222
  14. Liu, Q., Cai, W., Wang, X., Hu, H., Sun, X., Pan, X., & Wang, A. (2023). Recent death early warning value of ECG changes in patients with NSCLC. Medicine, 102(46), e35698. https://doi.org/10.1097/md.0000000000035698
  15. Luo, M., Duan, C., Qiu, J., Li, W., Zhu, D., & Cai, W. (2015). Diagnostic Value of Multidetector CT and Its Multiplanar Reformation, Volume Rendering and Virtual Bronchoscopy Postprocessing Techniques for Primary Trachea and Main Bronchus Tumors. PLoS ONE, 10(9), e0137329. https://doi.org/10.1371/journal.pone.0137329
  16. Choi, J., Tocco, B., Smith, A., Ahmad, S., Josephides, E., & Bille, A. (2023). Multimodality Treatment and Salvage Surgery for the Treatment of Lung Cancer. Cancers , 15 (14), 3586. https://doi.org/10.3390/cancers15143586
  17. Wieland, J., Hoppe, B. S., Rausch-Osian, S. M., King, J. C., Sierra, A., Hiemenz, J. W., Bradley, J., Pham, D. C., Jones, L. M., Yeung, A. R., Hopper, K., Mendenhall, N. P., & Hitchcock, K. E. (2019). Survivor and Caregiver Expectations and Preferences Regarding Lung Cancer Treatment. International Journal of Particle Therapy ,6 (2), 42–49. https://doi.org/10.14338/ijpt-19-00072.1
  18. Menis, J., & Reck, M. (2020). Checkpoint Inhibitors in SCLC: How Much Can We Trust in Randomized Cohorts of Phase I/II Trials? Journal of Thoracic Oncology , 15 (3), 308–310. https://doi.org/10.1016/j.jtho.2019.11.031